BioCentury
ARTICLE | Company News

EpiGenesis, Genta deal

July 30, 2001 7:00 AM UTC

GNTA non-exclusively licensed several patents to EpiGenesis covering methods, compositions and processes for in vitro and in vivo inhibition of protein synthesis by antisense oligonucleotides. GNTA wi...